Rosenblum Mark J 4
4 · Salarius Pharmaceuticals, Inc. · Filed Dec 4, 2020
Insider Transaction Report
Form 4
Rosenblum Mark J
Exec VP Finance, CFO
Transactions
- Award
Stock Option (right to buy)
2020-12-02+80,000→ 80,000 totalExercise: $0.74Exp: 2030-12-01→ Common Stock (80,000 underlying)
Footnotes (1)
- [F1]25% of the options are fully vested on December 1, 2021, and 1/36 of the remaining options vest on each monthly anniversary thereafter.